Antibody formation after vaccination against salmonellosis in adults and geriatric patients with urinary tract infection.
Explore the source record for details and available documents.
Age Factors↗
Biomedical subjects
A Kasanen
Publications and source records attributed to A Kasanen.
Cardiovascular diseases in persons aged 65 years and over in Turku.
Explore the source record for details and available documents.
Aged↗
The effects of some anti-inflammatory agents on the urinary excretion of acid mucopolysaccharides in the rat.
Explore the source record for details and available documents.
Acetaminophen↗
[Nonspecific infection as an early symptom of urinary tract tuberculosis].
Explore the source record for details and available documents.
Bacteriuria↗
[The dentition of the aged in Turku in the light of a sampling study].
Explore the source record for details and available documents.
Aged↗
[The nephrotoxicity of drugs].
Explore the source record for details and available documents.
Analgesics↗
The prognosis of kidney damage and anemia in the analgesic abuser.
Explore the source record for details and available documents.
Analgesics↗
Social stress and living habits in the etiology of peptic ulcer.
Explore the source record for details and available documents.
Adult↗
Urinary lactic dehydrogenase activity in urinary tract infection.
Explore the source record for details and available documents.
Adult↗
Eating and smoking habits of patients with myocardial infarction.
Explore the source record for details and available documents.
Adult↗
[A weekly dose of "long-acting" sulfonamide (4-sulfanilamido-5,6-dimethoxypyrimidine) in the treatment of urinary tract infections in the aged].
Explore the source record for details and available documents.
Aged↗
[The state of health of the aged in Turun-Porin. Investigation of healthy and sick needy people in populated districts of the Turun region in 1963].
Explore the source record for details and available documents.
Aged↗
Trimethoprim alone in the treatment of urinary tract infections: eight years of experience in Finland.
In Finland the usage of trimethoprim (TMP) alone constitutes about 25% of all drug usage for urinary tract infections. Despite this widespread use the proportion of TMP-resistant strains is almost same as it is in countries where only the combination of trimethoprim-sulfamethoxazole (TMP-SMZ) has been used. In general, strains resistant to TMP were seldom found; only in closed wards did the use of trimethoprim result in an increase in the proportion of resistant strains. In the treatment of acute urinary tract infections, TMP alone (dose, 160 mg taken twice daily for seven days) gave a result as good as that of TMP-SMZ (94.5% vs. 90.6%) and a better result than cephalexin (98.3% vs. 82.1%). TMP proved suitable as a single agent in the treatment of urinary tract infections in outpatients. In a study of long-term treatment, TMP (dose, 100 mg taken once daily), was more effective than nitrofurantoin, methenamine hippurate, TMP-SMZ, or placebo. Fewer adverse effects were associated with TMP than with the other drugs.
Acute Disease↗